Mavik and Palindromic rheumatism - a phase IV clinical study of FDA data

Summary:

Palindromic rheumatism is reported as a side effect among people who take Mavik (trandolapril), especially for people who are female, 40-49 old, also take Lyrica, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Palindromic rheumatism when taking Mavik. It is created by eHealthMe based on reports of 3,071 people who have side effects when taking Mavik from the FDA, and is updated regularly.

What is Mavik?

Mavik has active ingredients of trandolapril. It is often used in high blood pressure. eHealthMe is studying from 3,145 Mavik users. Check the latest studies of Mavik.

What is Palindromic rheumatism?

Palindromic rheumatism (sudden and rapidly developing attacks of arthritis) is found to be associated with 22 drugs and 63 conditions by eHealthMe. Check the latest studies of Palindromic rheumatism.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

3,071 people reported to have side effects when taking Mavik.
Among them, 20 people (0.65%) have Palindromic rheumatism.

Could Mavik cause Palindromic rheumatism?

Among these 20 people:

What is the gender of people who have Palindromic rheumatism when taking Mavik? *

female: 100 %
male: 0.0 %

What is the age of people who have Palindromic rheumatism when taking Mavik? *

What are other drugs people take besides Mavik? *

Xeljanz: 20 people, 100.00%
Lyrica: 20 people, 100.00%
Amlodipine: 19 people, 95.00%
Erelzi: 8 people, 40.00%
Prednisone: 6 people, 30.00%
Naproxen: 6 people, 30.00%
Methotrexate: 6 people, 30.00%
Gabapentin: 6 people, 30.00%
Folic Acid: 6 people, 30.00%
Hydroxychloroquine Sulfate: 4 people, 20.00%

What are other side effects people have besides Palindromic rheumatism? *

Weight Decreased: 20 people, 100.00%
Malaise (a feeling of general discomfort or uneasiness): 20 people, 100.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 20 people, 100.00%
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 20 people, 100.00%
Cough: 20 people, 100.00%
Drowsiness: 20 people, 100.00%
Drug Ineffective: 20 people, 100.00%
Exostosis (formation of new bone on the surface of a bone): 20 people, 100.00%
Fall: 20 people, 100.00%
Fibromyalgia (a long-term condition which causes pain all over the body): 20 people, 100.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 20 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Mavik and have Palindromic rheumatism?

- Check whether Palindromic rheumatism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mavik:

Mavik (3,145 reports)

Browse all side effects of Mavik:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Palindromic rheumatism:

Palindromic rheumatism (22 drugs)

Browse all the conditions that are associated with Palindromic rheumatism:

Palindromic rheumatism (63 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on trandolapril (the active ingredients of Mavik) and Mavik (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.